Pharma Industry Seeing Reduction in Data Breach Costs, But Still Have Much to Do
Insights from IBM’s Cost of a Data Breach Report on the Pharmaceutical Industry shows that while the overall cost has improved, there are clear areas of risk that need to be addressed.
Please follow and like us:
